Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

RAD to present at NWR Virtual Healthcare Conference

Tuesday, March 19, 2024 1 min read
Key Takeaway: Radiopharm Theranostics (RADX) is set to present at the NWR Virtual Healthcare Conference. The company has recently made strides in its clinical programs, including dosing the first patient in a Phase 1/2a clinical study of BetaBart (RV-01). This participation highlights RAD's commitment to advancing its therapeutic developments.

Market Sentiment Analysis

POSITIVE FACTORS

  • RAD is actively participating in a healthcare conference.
  • The company has made significant clinical advancements.
  • Positive updates across multiple programs indicate growth.

Full Press Release Details

• Announcements
• March 19, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• January 5, 2024
• Announcements
• June 20, 2024
• Announcements
• July 31, 2024
• Announcements
• March 12, 2024

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is the NWR Virtual Healthcare Conference?

The NWR Virtual Healthcare Conference is an event where companies present their latest developments.

What clinical study is RADX involved in?

RADX is conducting a Phase 1/2a clinical study of BetaBart (RV-01).

What recent advancements has RADX made?

RADX has provided positive updates across its clinical programs.

Who is presenting at the conference?

Radiopharm Theranostics (RADX) will be presenting at the conference.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics NWR Virtual Healthcare Conference BetaBart clinical study
Last updated: Mar 19, 2024